Physician Wealth Advisors’s Lexeo Therapeutics LXEO Stock Holding History

Physician Wealth Advisors’s Portfolio LXEO Stock Details LXEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$945	Buy	+203	New	+$1.1K	﹤0.01%	1866

Other funds holding LXEO

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Physician Wealth Advisors's LXEO Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Lexeo Therapeutics (LXEO) in Q2 2026: 203 shares worth $945. The stake represents ﹤0.01% of the portfolio and ranks #1866 among its holdings.

9 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

Physician Wealth Advisors held 203 shares of Lexeo Therapeutics worth $945 as of Q2 2026.
Lexeo Therapeutics was a new Physician Wealth Advisors position in Q2 2026.
Lexeo Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1866 holding.
9 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.